drugset / Trial / NCT07611240

Sevoflurane vs Propofol Anesthesia in Obese Patients Undergoing Lumbar Surgery

NCT07611240

Recruiting 70 enrolled Ataturk University
RandomizedParallel-groupSingle-blindBasic science

Summary

This randomized, single-center, single-masked clinical trial aims to compare the immunomodulatory effects of sevoflurane-based inhalational anesthesia and propofol-based total intravenous anesthesia in obese patients undergoing elective lumbar instrumentation surgery. Seventy patients will be randomized into two groups: a propofol group and a sevoflurane group. Blood samples will be collected preoperatively, at postoperative 6 hours, and at postoperative 24 hours. Pentraxin-3 and serum amyloid A levels will be evaluated as primary inflammatory biomarkers together with IL-6, TNF-α, CRP, glucose, and complete blood count parameters.

Timeline

Start
2025-06-15
Primary completion
2026-06-15
Completion
2026-06-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule 4 mg/kg Intravenous
Subject Propofol Small molecule 10 mg/kg Intravenous
Subject Sevoflurane Other / unclassified 1 unknown Inhaled
Subject Sevoflurane Other / unclassified 1.3 unknown Inhaled

Indications